What Labs Should Your Doctor Run Now That You're on a GLP-1?

GLP-1 receptor agonists like semaglutide and tirzepatide can produce significant changes in the body — not just in weight, but in blood sugar, kidney function, liver health, and more. Routine lab monitoring helps your provider track these changes, catch any early warning signs, and confirm that the medication is doing what it's supposed to do. Here's a practical overview of the key tests worth discussing with your doctor.

Why Lab Monitoring Matters on a GLP-1

GLP-1 medications work by suppressing appetite, slowing digestion, and influencing multiple metabolic pathways. These effects are generally beneficial, but they can also create conditions that warrant monitoring — for example, reduced food intake can affect nutritional status, and gastrointestinal side effects like nausea can occasionally lead to dehydration that stresses the kidneys. Baseline labs before starting treatment give your provider a reference point, making it easier to distinguish between pre-existing conditions and medication-related changes.

Blood Sugar and Metabolic Markers

• HbA1c (glycated hemoglobin): Reflects your average blood sugar over the past 2–3 months. This is one of the primary markers for assessing how well the medication is managing glucose levels, particularly for people with type 2 diabetes or prediabetes.
• Fasting glucose: A snapshot of blood sugar at a single point in time. Useful alongside HbA1c for a fuller picture of glycemic control.
• Fasting insulin: Can help assess insulin resistance, which is a common underlying factor in metabolic weight gain.

Kidney Function

GLP-1 medications are generally considered kidney-protective in people with diabetes, but dehydration from nausea or vomiting can occasionally stress the kidneys. Your provider may monitor:

• Creatinine and eGFR (estimated glomerular filtration rate): The primary markers for kidney filtration capacity.
• BUN (blood urea nitrogen): Another indicator of kidney function and hydration status.
• Urine albumin-to-creatinine ratio: Relevant for people with diabetes or existing kidney disease.

Liver Function

Many people who start GLP-1 medications have metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease. Weight loss can improve liver health significantly, but rapid weight loss can occasionally cause a temporary rise in liver enzymes. Monitoring ALT and AST helps track liver health over time and document improvements as fat loss progresses.

Thyroid Function

GLP-1 medications carry an FDA-mandated warning regarding thyroid C-cell tumors observed in animal studies, though this has not been confirmed in humans. TSH (thyroid-stimulating hormone) monitoring is particularly important for people who are already taking thyroid medication, since significant weight loss can alter how much thyroid hormone the body needs.

Lipids and Cardiovascular Markers

• Lipid panel (total cholesterol, LDL, HDL, triglycerides): Weight loss typically improves lipid profiles, and tracking these changes helps quantify cardiovascular benefit.
• ApoB: A more precise marker of cardiovascular risk than LDL alone, increasingly used by providers focused on long-term heart health.
• Blood pressure: Not a lab test, but worth monitoring at each visit — GLP-1-related weight loss often leads to meaningful reductions.

Nutritional Status

Reduced appetite means reduced food intake, which can lead to nutritional gaps over time — especially if the diet isn't well-balanced. Depending on your health history and eating patterns, your provider may check:

• Vitamin B12: Reduced intake of animal proteins can lower B12 levels over time.
• Vitamin D: Deficiency is common in the general population and can worsen with reduced food variety.
• Iron and ferritin: Particularly relevant for women and for people who eat less red meat.
• Magnesium: Often low in people with metabolic conditions and can be further affected by dietary changes.

Pancreatic Health

Pancreatitis is a rare but known potential side effect of GLP-1 medications. Lipase is the primary marker used to evaluate pancreatic inflammation. Routine lipase testing isn't necessary for everyone, but it may be ordered if you develop persistent abdominal pain or other symptoms that raise concern.

How Often Should You Get Labs Done?

A common approach is to establish baseline labs before starting treatment, then recheck key markers at 3 months and again at 6 months. After that, stable patients typically move to every 6–12 months, with more frequent testing if dose adjustments are made or if any results warrant closer follow-up. Your provider will tailor this schedule to your individual health history and any conditions you're managing alongside weight loss.

If you develop new or concerning symptoms at any point — persistent abdominal pain, unusual fatigue, signs of dehydration, or significant changes in urination — prompt testing is appropriate rather than waiting for a scheduled check-in.